News

Quantum BioPharma Completes Key Toxicity Studies for MS Drug

Quantum BioPharma Completes Key Toxicity Studies for MS Drug

Key Milestone in Lucid-MS Development

Quantum BioPharma Ltd. (NASDAQ: QNTM) has reached a significant milestone in its drug development journey for Multiple Sclerosis with the completion of dosing in critical 90-day repeated dose oral toxicity and toxicokinetic studies for its promising candidate, Lucid-21-302, also known as Lucid-MS. This advancement is crucial for supporting an Investigational New Drug (IND) application with the US FDA, which allows for further clinical trials.

Advancing Clinical Development

Dr. Andrzej Chruscinski, the Vice-President of Scientific and Clinical Affairs at Quantum BioPharma, expressed his enthusiasm about this achievement, stating, "These results will play a pivotal role in our IND submission planned for later this year." The completion of these studies propels the company closer to moving into Phase 2 trials, which are critical for evaluating the efficacy of Lucid-21-302 in patients diagnosed with Multiple Sclerosis.

Company Leaders Share Excitement

CEO Zeeshan Saeed shared his excitement regarding Lucid-21-302, emphasizing its potential as a first-in-class treatment. "Completing these studies brings us one step closer to making a meaningful difference in the lives of those living with Multiple Sclerosis," he stated. Saeed’s optimism reflects the company’s broader mission to deliver innovative treatments for challenging conditions, including neurodegenerative and metabolic disorders.

About Quantum BioPharma

Quantum BioPharma, listed on NASDAQ as QNTM, is actively working on a portfolio of advanced biotech solutions that target severe health issues. Its ongoing research into Lucid-MS—a patented new chemical entity—aims to prevent and reverse myelin degradation, a significant factor in the progression of Multiple Sclerosis. Exploration of therapies like Lucid-MS demonstrates the company’s commitment to addressing unmet medical needs.

Innovative Products and Future Prospects

Besides its focus on Lucid-MS, Quantum BioPharma's evolution includes the development of a consumer product, unbuzzd™, which has been successfully integrated into a venture with Celly Nutrition Corp. The collaboration not only empowers Quantum BioPharma with a substantial ownership stake but also establishes a revenue generation model through royalty arrangements. This diverse strategic direction underscores Quantum's innovative spirit and entrepreneurial approach in the biopharmaceutical landscape.

Investor Relations and Contact Information

To foster ongoing communication with investors and stakeholders, Quantum BioPharma maintains dedicated contact lines. For investor inquiries, individuals can reach out via email at IR@QuantumBioPharma.com. General inquiries can be directed to info@QuantumBioPharma.com. The company is dedicated to transparency and aims to keep stakeholders informed about its progress and future developments.

Frequently Asked Questions

What is Lucid-21-302?

Lucid-21-302, or Lucid-MS, is a novel therapeutic candidate developed by Quantum BioPharma aimed at treating Multiple Sclerosis by preventing myelin degradation.

What are toxicity studies and why are they important?

Toxicity studies assess the safety profile of a drug. They are crucial for obtaining regulatory approvals necessary for progressing to human trials.

What are the future plans for Lucid-21-302?

The next steps include analyzing the toxicity study data and preparing for Phase 2 clinical trials to assess the efficacy of Lucid-21-302 in patients with Multiple Sclerosis.

How does Quantum BioPharma generate revenue?

The company generates revenue by partnering with Celly Nutrition, which markets unbuzzd™, and through royalty payments linked to product sales.

How can I contact Quantum BioPharma?

For inquiries, individuals can reach Quantum BioPharma via their investor relations email or general inquiries email provided on their website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 53

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
Secrets to Selecting Fresh Seafood for Your Boil

Updated Category News Views 129

Navigating the Waters of Seafood Quality When it comes to throwing together a proper Louisiana seafood boil, your whole evening could sink or swim based on seafood freshness. Jonathan Sumich, a grocery veteran from Oak Point Fresh Market, spills the beans on picking the cream of the crop. Plan it right, and you’re the hero of the feast. Ignore these tips, and you might...

Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions

Updated Category News Views 74

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 107

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 161

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Pine AI Unveils AI Studio & Real-World Call Feature

Updated Category News Views 179

Push Your Expectations: Pine AI Takes the Stage Here's a twist in tech worth a double take. Pine AI is shaking up the AI world with a brash blend of video genius and actual chat capabilities. Somehow, merely weeks after setting the tech scene ablaze with its AI-focused computer, it's already rolling out new applications faster than hotcakes on a skillet. But let’s chew...

Continue Reading
Honoring Boston's Architects Changing the Game

Updated Category News Views 60

Celebrating Architecture's Influencers in Boston Every now and then, a profession needs a wake-up call. Stirring the pot, shaking the roots, call it what you will, but when folks rally together with a shared vision, change doesn't just seem possible — it's inevitable. On November 12, the Boston Society of Architects (BSA) and Architecture in Common (AiC) did just that...

Continue Reading
Toronto's Distillery Winter Village Kicks Off 2026

Updated Category News Views 202

Toronto's Holiday Spirit Ignites Toronto just cranked up the holiday spirit with the lighting of a 55-foot Christmas tree at The Distillery Winter Village. Let me tell you, it's a sight that could warm your innards on the coldest winter night. Presented by Quince, this winter wonderland opened its doors for 2026—and it's looking like they're pulling out all the stops...

Continue Reading
Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 136

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 80

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading

Top 5 Most Recently Viewed Articles

Lectra Revolutionizes Fashion Industry with Valia Technology

Updated Category News Views 94

Lectra Launches Valia Fashion to Transform Apparel Production Lectra has introduced an innovative platform that significantly enhances the business processes of fashion companies. This digital platform, known as Valia Fashion, plays a pivotal role in assisting these companies during their transition towards Industry 4.0, making production more efficient and sustainable....

Continue Reading
XPENG's Q2 2026 Results: Gains and Challenges

Updated Category News Views 31

XPENG's Revenue Moves Amid Persistent Losses When you sift through the second quarter numbers for 2026 from XPENG (NYSE: XPEV), it’s like inspecting a mixed bag tossed out of a speeding car. You gotta separate the wins from the weight pulling it down. On the bright side, revenues hit a steady RMB19.74 billion, riding high with a neat 51.5% boost from Q1. But let's not...

Continue Reading
MongoDB Inc Records Impressive Growth and Increases Guidance

Updated Category News Views 201

Exceptional Q2 Performance by MongoDB Inc MongoDB, Inc. (NASDAQ: MDB) has recently delivered impressive second-quarter results, showcasing remarkable progress in its performance metrics. Following the closure of Tuesday's trading, the financial results were unveiled, revealing key statistics that highlight the company's accelerating growth. Key Financial Highlights For...

Continue Reading
Ka'Chava's Rise as 2025's Premier Meal Replacement Shake

Updated Category News Views 394

Ka'Chava Ranks as the Top Meal Replacement Shake for 2025 Consumer365 has spotlighted Ka'Chava as the leading all-in-one nutrition shake of the year, highlighting its comprehensive approach to healthy eating. This recognition stems from an assessment that considers the extensive ingredient profile, proven health benefits, and the variety of flavors available. Why Ka'Chava...

Continue Reading
JVK Law Launches with Promises of Strong Investor Protection

Updated Category News Views 393

Introduction to JVK Law and Its Mission Today marks an exciting new chapter in the world of corporate governance with the launch of JVK Law. This innovative, trial-ready firm is dedicated to the protection of investor rights, aiming to hold corporate insiders accountable and provide clarity in our complex global capital markets. Founded by noted attorney Jeroen van...

Continue Reading